CLINICAL_TRIALS
trial_result
· 2021-12-02
Clinical Trial Update: Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia [Phase 2]
Summary
Phase 2 clinical trial update on hematopoietic stem cell transplantation in high-risk Fanconi anemia patients; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Fanconi Anemia | Phase 2 | Status: COMPLETED | Results posted: 2021-12-02